BERTARINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.569
AS - Asia 1.417
EU - Europa 665
SA - Sud America 176
Continente sconosciuto - Info sul continente non disponibili 39
AF - Africa 26
Totale 3.892
Nazione #
US - Stati Uniti d'America 1.450
SG - Singapore 385
IT - Italia 374
CN - Cina 373
VN - Vietnam 165
BD - Bangladesh 162
BR - Brasile 121
HK - Hong Kong 96
KR - Corea 66
GB - Regno Unito 62
CA - Canada 52
DE - Germania 41
IN - India 37
RU - Federazione Russa 36
FR - Francia 28
MX - Messico 28
AR - Argentina 24
IQ - Iraq 21
TR - Turchia 20
FI - Finlandia 18
JP - Giappone 18
ID - Indonesia 15
ES - Italia 14
NL - Olanda 14
PL - Polonia 12
SE - Svezia 12
CR - Costa Rica 10
PK - Pakistan 10
EC - Ecuador 7
ZA - Sudafrica 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
CO - Colombia 6
PH - Filippine 6
UA - Ucraina 6
CL - Cile 5
HR - Croazia 5
IL - Israele 5
LT - Lituania 5
VE - Venezuela 5
AT - Austria 4
EG - Egitto 4
GT - Guatemala 4
JM - Giamaica 4
JO - Giordania 4
NI - Nicaragua 4
PE - Perù 4
TT - Trinidad e Tobago 4
BE - Belgio 3
DZ - Algeria 3
HN - Honduras 3
IE - Irlanda 3
MA - Marocco 3
MY - Malesia 3
PR - Porto Rico 3
PT - Portogallo 3
RS - Serbia 3
SA - Arabia Saudita 3
TH - Thailandia 3
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
KW - Kuwait 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SN - Senegal 2
SV - El Salvador 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
Totale 3.852
Città #
Singapore 255
Ashburn 190
San Jose 156
Hefei 134
Santa Clara 119
Council Bluffs 100
Hong Kong 82
Los Angeles 72
Ho Chi Minh City 58
New York 53
Beijing 51
Seoul 48
Modena 45
Hanoi 33
Bologna 31
Chicago 26
London 26
Milan 26
Dallas 25
Buffalo 20
Orem 20
São Paulo 17
Biên Hòa 15
Brooklyn 15
Frankfurt am Main 15
Lauterbourg 15
Mexico City 15
Shanghai 15
The Dalles 15
Chennai 14
Boardman 13
Naples 13
Tokyo 13
Denver 12
Rome 12
Turin 12
Helsinki 11
Montreal 11
Reggio Emilia 11
Salt Lake City 11
Shenzhen 11
Ho Man Tin 10
Houston 10
Manchester 10
Moscow 10
Chandler 9
Jakarta 9
Poplar 9
Rio de Janeiro 9
Warsaw 9
Atlanta 8
Baghdad 8
Des Moines 8
San José 8
Toronto 8
Amsterdam 7
Ankara 7
Brasília 7
Buenos Aires 7
Da Nang 7
Mishawaka 7
Palermo 7
Washington 7
Yalova 7
Boston 6
Lappeenranta 6
North Bergen 6
Nuremberg 6
Philadelphia 6
Seattle 6
Charlotte 5
Haiphong 5
Istanbul 5
Kent 5
Langerwehe 5
Milwaukee 5
Newark 5
Parma 5
Phoenix 5
San Martino in Rio 5
Amman 4
Casalgrande 4
Cleveland 4
Curitiba 4
Dhaka 4
Elizabeth 4
Gwanak-gu 4
Jacksonville 4
Johannesburg 4
Lahore 4
Managua 4
Tianjin 4
Wilmington 4
Zagreb 4
Athens 3
Baltimore 3
Bari 3
Basra 3
Catania 3
Changsha 3
Totale 2.184
Nome #
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 236
A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol 227
Lipidomic profiling of MASLD: identifying lipid biomarkers for detection and stratification of disease severity 208
– IN SILICO SCREENING OF NOVEL INHIBITORS OF BETA-LACTAMASES 207
Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS: a new tool for drug discovery 201
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer 200
In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body 196
Mapping the lipid landscape of MASLD: insights into disease progression through lipidomic patterns 190
Looking for broad-spectrum inhibitors targeting carbapenemases 188
Identifying lipid patterns through lipidomic profiling for MASLD detection and severity stratification 187
Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria 168
ECOTOXICOLOGICAL PROFILING AND LEADS PRIORITIZATION THROUGH MACHINE LEARNING-BASED APPROACH FOR THE DESIGN OF SAFER ANTIPARASITIC AGENTS 166
Targeted metabolomics for the analysis of p-Cresol in mouse brain by HPLC-ESI-MS/MS 163
Targeted metabolomics for the analysis of p-cresol in mouse brain by HPLC-ESI-MS/MS 161
Targeted Metabolomics for the Analysis of p-Cresol in Mouse Brain: Impact of Biological Sex and Strain 158
From Drug Repurposing to Benzoxaborole Synthesis: Targeting LexA in Bacterial SOS Response 134
Lichen secondary metabolites as potential inhibitors of viral 3-chymotrypsin-like protease (3CLpro) 132
Targeting the Transcriptional Repressor LexA to Overcome Bacterial Resistance A Strategy Based on Drug Repurposing and Lead Optimization 132
Fighting Antibiotic Resistance • Drug Repurposing and Structure-Based Optimization of Benzoxaboroles as LexA Inhibitors 129
Mechanism of non-competitive inhibition of the SARS-CoV-2 3CL protease dimerization: Therapeutic and clinical promise of the lichen secondary metabolite perlatolinic acid 124
Broad spectrum metallo beta-lactamases inhibitors: New tools against clinically-relevant carbapenemases 111
Drug Discovery and preclinical Development for Human and Animal African Trypanosomiasis: Profiling of a collection of Natural Compounds with ADME-(Eco)Toxicity properties 99
Para-Cresol and the Brain: Emerging Role in Neurodevelopmental and Neurodegenerative Disorders and Therapeutic Perspectives 76
A sesquiterpene-rich essential oil from Cannabis sativa L. attenuates symptoms and neuroinflammation in experimental autoimmune encephalomyelitis model through a CB2-mediated signalling 58
Benzoxaborole-Based Inhibitors Block LexA Autocleavage and Suppress SOS-Dependent Adaptive Phenotypes in Escherichia coli 30
Leveraging Ecotoxicity Parameters and Machine Learning to Rethink the Drug Discovery Pipeline 11
Totale 3.892
Categoria #
all - tutte 11.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.590


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 0 0 0 0 0 0 0 0 9 10
2022/202338 2 2 2 3 3 13 1 3 5 3 0 1
2023/202456 4 4 1 1 9 3 4 9 2 6 7 6
2024/2025416 8 0 9 25 59 57 36 25 50 28 64 55
2025/20262.479 63 49 233 358 367 190 225 139 226 178 247 204
2026/2027884 127 197 195 297 68 0 0 0 0 0 0 0
Totale 3.892